Callan JMB Inc (CJMB)

Callan JMB Inc. experienced consistent buying activity from leadership. Chief Medical Officer David J. Croyle executed the most recent transactions on March 20, 2026. These acquisitions follow a series of purchases by executives and other insiders throughout late 2025 and early 2026, reflecting ongoing accumulation of equity by company personnel.
Ticker: CJMB Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Callan JMB Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Croyle David J Chief Medical Officer Officer Large shareholder
Transaction date
Purchase
Price
200.84
Quantity 81,326 -44.5%
Value US$2,947,894
2.9
Croyle David J Chief Medical Officer Officer Large shareholder
Transaction date
Purchase
Price
195.66
Quantity 76,941 -32.5%
Value US$4,778,004
1.7
Dial Gerald Non-Executive Director
Transaction date
Purchase
Price
483.54
Quantity 71,039 -18.6%
Value US$4,943,770
1.7
Dial Gerald Non-Executive Director
Transaction date
Purchase
Price
1.20
Quantity 1,539 +333.8%
Value US$1,847
1.7
Dial Gerald Non-Executive Director
Transaction date
Purchase
Price
1.22
Quantity 461 +inf%
Value US$562
3.5
Williams Wayne D CEO, Chairman and President Executive Director Large shareholder
Transaction date
Purchase
Price
1.73
Quantity 5,000 +6.3%
Value US$8,650
3.5
Williams Wayne D CEO, Chairman and President Executive Director Large shareholder
Transaction date
Purchase
Price
1.70
Quantity 10,810 +15.8%
Value US$18,377
3.5
Williams Wayne D CEO, Chairman and President Executive Director Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 4,926 +0.2%
Value US$8,620
3.5
Williams Wayne D CEO, Chairman and President Executive Director Large shareholder
Transaction date
Purchase
Price
1.79
Quantity 62 +0.0%
Value US$111
3.5
Williams Wayne D CEO, Chairman and President Executive Director Large shareholder
Transaction date
Purchase
Price
1.65
Quantity 30,856 +81.9%
Value US$50,912
3.5
Williams Wayne D CEO, Chairman and President Executive Director Large shareholder
Transaction date
Purchase
Price
1.65
Quantity 13,689 +54.8%
Value US$22,587
1.7
Duke Liberty Smith Non-Executive Director
Transaction date
Purchase
Price
1.52
Quantity 612 +68.0%
Value US$930
1.7
Duke Liberty Smith Non-Executive Director
Transaction date
Purchase
Price
1.56
Quantity 900 +inf%
Value US$1,404
2.9
Croyle David J Chief Medical Officer Officer Large shareholder
Transaction date
Purchase
Price
4.50
Quantity 25,000 +3.3%
Value US$112,500
3.5
Williams Wayne D CEO and President Executive Director Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 25,000 +inf%
Value US$100,000
3.5
Williams Wayne D CEO and President Executive Director Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 25,625 +inf%
Value US$102,500
3.5
Williams Wayne D CEO and President Executive Director Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 12,500 +0.6%
Value US$50,000
2.9
Croyle David J Chief Medical Officer Officer Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 24,375 +inf%
Value US$97,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-26 2026-03-20 B Purchase

Chief Medical Officer

Officer Large shareholder
81,326 -44.5%
200.84
US$2,947,894
81,326 -44.5% 200.84 US$2,947,894
2026-03-10 2026-03-06 B Purchase

Chief Medical Officer

Officer Large shareholder
76,941 -32.5%
195.66
US$4,778,004
76,941 -32.5% 195.66 US$4,778,004
2026-06-01 2025-12-30 B Purchase Non-Executive Director
71,039 -18.6%
483.54
US$4,943,770
71,039 -18.6% 483.54 US$4,943,770
2026-01-06 2025-12-30 B Purchase Non-Executive Director
1,539 +333.8%
1.20
US$1,847
1,539 +333.8% 1.20 US$1,847
2026-01-06 2025-12-30 B Purchase Non-Executive Director
461 +inf%
1.22
US$562
461 +inf% 1.22 US$562
2025-12-18 2025-12-16 B Purchase

CEO, Chairman and President

Executive Director Large shareholder
5,000 +6.3%
1.73
US$8,650
5,000 +6.3% 1.73 US$8,650
2025-12-15 2025-12-15 B Purchase

CEO, Chairman and President

Executive Director Large shareholder
10,810 +15.8%
1.70
US$18,377
10,810 +15.8% 1.70 US$18,377
2025-12-15 2025-12-12 B Purchase

CEO, Chairman and President

Executive Director Large shareholder
4,926 +0.2%
1.75
US$8,620
4,926 +0.2% 1.75 US$8,620
2025-12-15 2025-12-11 B Purchase

CEO, Chairman and President

Executive Director Large shareholder
62 +0.0%
1.79
US$111
62 +0.0% 1.79 US$111
2025-12-12 2025-12-11 B Purchase

CEO, Chairman and President

Executive Director Large shareholder
30,856 +81.9%
1.65
US$50,912
30,856 +81.9% 1.65 US$50,912
2025-12-12 2025-12-10 B Purchase

CEO, Chairman and President

Executive Director Large shareholder
13,689 +54.8%
1.65
US$22,587
13,689 +54.8% 1.65 US$22,587
2025-12-10 2025-12-09 B Purchase Non-Executive Director
612 +68.0%
1.52
US$930
612 +68.0% 1.52 US$930
2025-12-10 2025-12-08 B Purchase Non-Executive Director
900 +inf%
1.56
US$1,404
900 +inf% 1.56 US$1,404
2025-04-03 2025-03-27 B Purchase

Chief Medical Officer

Officer Large shareholder
25,000 +3.3%
4.50
US$112,500
25,000 +3.3% 4.50 US$112,500
2025-03-14 2025-02-05 B Purchase

CEO and President

Executive Director Large shareholder
25,000 +inf%
4.00
US$100,000
25,000 +inf% 4.00 US$100,000
2025-03-14 2025-02-05 B Purchase

CEO and President

Executive Director Large shareholder
25,625 +inf%
4.00
US$102,500
25,625 +inf% 4.00 US$102,500
2025-03-14 2025-02-05 B Purchase

CEO and President

Executive Director Large shareholder
12,500 +0.6%
4.00
US$50,000
12,500 +0.6% 4.00 US$50,000
2025-03-14 2025-02-05 B Purchase

Chief Medical Officer

Officer Large shareholder
24,375 +inf%
4.00
US$97,500
24,375 +inf% 4.00 US$97,500